Skip to main content

Year: 2023

Cognition Therapeutics Releases New Episode of “Conversations” Podcast Recorded at CTAD with Quantitative EEG Experts, Drs Willem de Haan and Philip Scheltens

PURCHASE, N.Y., Nov. 16, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company” or “Cognition”) has released its seventh Conversations video podcast episode: “Quantitative EEG – Effects of CT1812 on Measures of Synaptic Function in Alzheimer’s Disease.” This episode will feature a review and interactive discussion of the results from Cognition’s Phase 2 SEQUEL study, which were presented at the Clinical Trials on Alzheimer’s Disease (CTAD) conference. During the episode, Cognition Therapeutics’ CMO and head of R&D, Anthony Caggiano, M.D., Ph.D. moderates a discussion with two leading experts:Willem de Haan, M.D., Ph.D., Senior Researcher at the Alzheimer Center at Amsterdam University Medical Center Philip Scheltens, M.D., Managing Partner at EQT Life Sciences; Founder of the Alzheimer...

Continue reading

Morien Reports on Continuing Developments at the Donkin Mine

HALIFAX, Nova Scotia, Nov. 16, 2023 (GLOBE NEWSWIRE) — Morien Resources Corp. (“Morien” or the “Company”) (TSX-V:MOX), today provides an update on the Donkin Coal Mine (“Donkin” or the “Mine”) in Nova Scotia, owned and operated by Kameron Collieries (“Kameron”), upon which Morien has a 2% to 4% royalty interest. The Nova Scotia Department of Labour, Skills and Immigration (“DOL”), a provincial regulator for the Mine, held a press conference yesterday afternoon to report on the findings of an independent engineer contracted by DOL in September to complete a technical review of the Donkin Mine. The following news release from DOL provides additional information: https://novascotia.ca/news/release/?id=20231115003 Yesterday’s press conference follows Kameron’s decision on November 10, 2023, to lay off its remaining...

Continue reading

Safe Harbor Originates $3 Million First Lien Secured Loan for Multi-tenant Cannabis Industrial Building in California

GOLDEN, Colo., Nov. 16, 2023 (GLOBE NEWSWIRE) — SHF Holdings, Inc., d/b/a/ Safe Harbor Financial (“Safe Harbor” or the “Company”) (NASDAQ: SHFS), a leader in facilitating financial services and credit facilities to the regulated cannabis industry, today announced that it has facilitated the funding of a $3 million loan for a multi-tenant cannabis industrial building in California. Dan Roda, Executive Vice President & Chief Operating Officer of Safe Harbor Financial commented, “We continue to see strong demand from across the cannabis industry for loans with competitive rates to support long-term growth. Our unique ability to service these businesses with market-competitive credit not only enhances Safe Harbor’s position as a leading credit originator to the cannabis industry, it also demonstrates the scale of our powerful...

Continue reading

Yuengling’s Ice Cream Announces Acquisition of Cybersecurity Firm ReachOut Technology

Rick Jordan New President & CEO and a Director as Dickson and Bohorad Step Down ATLANTA, GA, Nov. 16, 2023 (GLOBE NEWSWIRE) — via NewMediaWire –Yuengling’s Ice Cream Corporation (“Yuengling’s” or the “Company”) (OTC: YCRM) is pleased to announce the acquisition of ReachOut Technology (“ReachOut”), Rick Jordan has assumed President & CEO role and been appointed a Director of Yuengling’s Ice Cream Corporation. Robert Bohorad, former President and CEO, and Everett Dickson, former Director, have stepped down but will assist with the transition. Everett Dickson, outgoing Director, expressed his enthusiasm about the acquisition, stating, “We are fortunate to have concluded a transaction with an economically strong and vibrant Managed Service Provider in the fast and increasingly important cybersecurity and IT space like ReachOut...

Continue reading

GigaCloud Technology Inc Announces Acquisition of Wondersign

Paving an Innovative Way for Advanced Technology and Expansive Retail Experiences WALNUT, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) — GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce solutions for large parcel merchandise, today announced that it has completed the acquisition of a 100% equity interest of Apexis, Inc., a Florida corporation dba Wondersign (“Wondersign”), for a total cash consideration of $10.0 million, subject to customary purchase price adjustments. Wondersign is a cloud-based interactive digital signage and e-catalog management SaaS company headquartered in Tampa, Florida with access to thousands of storefronts across the United States through its customers. Wondersign develops and maintains “Catalog Kiosk,” a leading digital catalog software that...

Continue reading

Warner Music Group Corp. Reports Results for Fiscal Fourth Quarter and Full Year Ended September 30, 2023

Financial HighlightsEclipsed $6 billion of total revenue for the first time in WMG’s history Acceleration in Q4 Streaming Growth Driven by Release Slate and Ad-Supported Improvement Continued Strength in Music Publishing with Double-Digit Revenue Growth for the Quarter and Full Year Strong Margin Expansion Outperformed Full-Year Expectations Achieved Robust Full-Year Operating Cash Flow Conversion of 56% in Line with TargetFor the three months ended September 30, 2023Total revenue increased 6%, or 5% in constant currency Digital revenue increased 8%, or 7% in constant currency Net income was $154 million versus $150 million in the prior-year quarter OIBDA increased 19% to $291 million versus $245 million in the prior-year quarter or 17% in constant currency Adjusted OIBDA increased 20% to $317 million versus $265 million in the prior-year...

Continue reading

WaveDancer Announces Merger Agreement with Firefly Neuroscience

– Merger to create NASDAQ-listed, commercial-stage AI-Enabled medical technology company focused on bringing FDA-cleared Brain Network Analytics platform to NASDAQ Capital Markets FAIRFAX, Va., Nov. 16, 2023 (GLOBE NEWSWIRE) — WaveDancer, Inc. (“WaveDancer”) (NASDAQ: WAVD) today announced that it has entered into a definitive merger agreement with privately held, commercial-stage, medical technology company, Firefly Neuroscience, Inc. (“Firefly”), to combine the companies in an all-stock transaction. The combined company will focus on continuing to develop and commercialize Firefly’s Artificial Intelligence driven Brain Network Analytics (BNA™) platform, which was previously cleared by the U.S. Food and Drug Administration (“FDA”). Upon closing, which is currently expected in Q1-2024, the combined company is expected to...

Continue reading

Q32 Bio and Homology Medicines Announce Merger Agreement

—The combined company will operate as Q32 Bio Inc., advancing the development of Q32 Bio’s two clinical development candidates, bempikibart (ADX-914) in Phase 2 for the treatment of atopic dermatitis (AD) and alopecia areata (AA), and ADX-097 entering Phase 2 for the treatment of complement disorders– –Q32 Bio has re-acquired worldwide development and commercial rights to bempikibart, an anti-IL-7Rα antibody inhibiting IL-7 and TSLP-mediated signaling, and remains on-track to report multiple topline Phase 2 results in 2H’24– –Concurrent $42 million private placement investment with new and existing investors supports clinical development through multiple milestones, including key Phase 2 readouts for bempikibart, initial ADX-097 proof-of-concept data by year-end 2024 and ADX-097 topline results in 2H’25– –Combined...

Continue reading

Gilat Completes Acquisition of DataPath, Inc.

The acquisition represents a strong step forward in Gilat’s strategy to increase its presence in the growing defense communications market PETAH TIKVA, Israel, Nov. 16, 2023 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that it has completed the acquisition of DataPath, Inc., a market leader in trusted communications for the US DoD Military and Government sectors. The transaction was approved by the Gilat Board of Directors and by DataPath’s Board of Directors and stockholders earlier this year, and it has received regulatory approvals, including the receipt of clearance from the Committee on Foreign Investment in the United States (CFIUS). “This acquisition is a strong step ahead in Gilat’s strategy to...

Continue reading

AYR Wellness Reports Third Quarter 2023 Results

Revenue up 5% Y/Y to $114.4 Million, Excluding Discontinued Operations GAAP Loss from Operations Improved 92% Y/Y to ($1.5) Million, Excluding Discontinued Operations Generated over $20 Million of Operating Cash Flow in the Third Quarter Adjusted EBITDA1 up 52% Y/Y to $28.4 Million, with Adjusted EBITDA Margin of 25% MIAMI, Nov. 16, 2023 (GLOBE NEWSWIRE) — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (“MSO”), is reporting financial results for the third quarter ended September 30, 2023. Unless otherwise noted, all results are presented in U.S. dollars. The following financial measures are reported as results from continuing operations due to the sale of the Company’s business in Arizona in March 2023, which are reported as discontinued...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.